{"id":"https://openalex.org/W7085642878","doi":"https://doi.org/10.5281/zenodo.17297702","title":"A Comprehensive Review of Current Trends and Regulatory Frameworks in Generic Drug Development","display_name":"A Comprehensive Review of Current Trends and Regulatory Frameworks in Generic Drug Development","publication_year":2025,"publication_date":"2025-10-08","ids":{"openalex":"https://openalex.org/W7085642878","doi":"https://doi.org/10.5281/zenodo.17297702"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.17297702","doi":"https://doi.org/10.5281/zenodo.17297702","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.17297702","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.5281/zenodo.17297702","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Chinna Reddy Palem*, Ravindar Rendla, Nishanth Kumar Nagamalli, Vamshi Krishna Lekkala, Sridhar Gumudevelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Chinna Reddy Palem*, Ravindar Rendla, Nishanth Kumar Nagamalli, Vamshi Krishna Lekkala, Sridhar Gumudevelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":{"value":3620,"currency":"USD","value_usd":3620},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.4558099,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8422999978065491,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8422999978065491,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.09549999982118607,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.02969999983906746,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/generic-drug-development","display_name":"generic drug development","score":0.9319999814033508},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9200000166893005},{"id":"https://openalex.org/keywords/quality-by-design","display_name":"quality by design","score":0.8569999933242798},{"id":"https://openalex.org/keywords/continuous-production","display_name":"continuous production","score":0.9909999966621399},{"id":"https://openalex.org/keywords/process-analytical-technology","display_name":"process analytical technology","score":0.9599999785423279},{"id":"https://openalex.org/keywords/excipient-selection","display_name":"excipient selection","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.5580000281333923},{"id":"https://openalex.org/keywords/regulatory-compliance","display_name":"regulatory compliance","score":0.7269999980926514},{"id":"https://openalex.org/keywords/developing-countries","display_name":"developing countries","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.6880999803543091},{"id":"https://openalex.org/C2776473838","wikidata":"https://www.wikidata.org/wiki/Q174165","display_name":"Innovator","level":3,"score":0.6876999735832214},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.6703000068664551},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.5812000036239624},{"id":"https://openalex.org/C2776396487","wikidata":"https://www.wikidata.org/wiki/Q506319","display_name":"Generic drug","level":3,"score":0.5174000263214111},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.5166000127792358},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.505299985408783},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.4724000096321106},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4697999954223633},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.4661000072956085},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.46239998936653137},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3612000048160553},{"id":"https://openalex.org/C2779606619","wikidata":"https://www.wikidata.org/wiki/Q17092524","display_name":"Interchangeability","level":2,"score":0.3465999960899353},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.3411000072956085},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3398999869823456},{"id":"https://openalex.org/C106436119","wikidata":"https://www.wikidata.org/wiki/Q836575","display_name":"Quality assurance","level":3,"score":0.3082999885082245},{"id":"https://openalex.org/C2988729646","wikidata":"https://www.wikidata.org/wiki/Q838129","display_name":"Process development","level":2,"score":0.2964000105857849},{"id":"https://openalex.org/C2778938233","wikidata":"https://www.wikidata.org/wiki/Q7180757","display_name":"Pharmaceutical manufacturing","level":2,"score":0.2930999994277954},{"id":"https://openalex.org/C2780449318","wikidata":"https://www.wikidata.org/wiki/Q18344773","display_name":"Critical quality attributes","level":3,"score":0.2924000024795532},{"id":"https://openalex.org/C2775924081","wikidata":"https://www.wikidata.org/wiki/Q55608371","display_name":"Control (management)","level":2,"score":0.27469998598098755},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.26910001039505005},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.26660001277923584},{"id":"https://openalex.org/C2779709869","wikidata":"https://www.wikidata.org/wiki/Q1292017","display_name":"Good manufacturing practice","level":3,"score":0.2538999915122986}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.17297702","doi":"https://doi.org/10.5281/zenodo.17297702","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.17297702","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.17297703","doi":"https://doi.org/10.5281/zenodo.17297703","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.17297703","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":null,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.17297702","doi":"https://doi.org/10.5281/zenodo.17297702","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.17297702","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Industry, innovation and infrastructure","id":"https://metadata.un.org/sdg/9","score":0.7207000255584717}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Generic":[0],"drug":[1,11,26,48,137],"development":[2,27,49],"is":[3],"a":[4,43,123],"scientifically":[5],"rigorous":[6],"process":[7,60],"distinct":[8],"from":[9,142],"innovator":[10,94],"development,":[12,138],"focusing":[13],"on":[14],"bioequivalence":[15],"to":[16,56,74,146],"ensure":[17,75],"comparable":[18],"safety,":[19],"efficacy,":[20],"and":[21,30,59,65,79,85,96,132,148,154,162],"therapeutic":[22],"outcomes.":[23],"As":[24],"innovation-driven":[25],"remains":[28],"time":[29],"cost":[31],"intensive,":[32],"many":[33],"pharmaceutical":[34],"industries":[35],"particularly":[36],"in":[37,92,157],"developing":[38],"countries":[39],"prioritize":[40],"generics":[41],"as":[42,106],"viable":[44],"alternative.":[45],"Current":[46],"generic":[47,136],"integrates":[50],"Quality":[51],"by":[52],"Design":[53],"(QbD)":[54],"principles":[55],"enhance":[57],"product":[58,159],"understanding,":[61],"while":[62],"continuous":[63],"manufacturing":[64,153],"Process":[66],"Analytical":[67],"Technology":[68],"(PAT)":[69],"tools":[70,156],"are":[71],"increasingly":[72],"adopted":[73],"real-time":[76],"quality":[77,95,161],"control":[78],"regulatory":[80,100,104,133],"compliance.":[81],"Despite":[82],"lower":[83],"costs":[84],"faster":[86],"timelines,":[87],"developers":[88],"face":[89],"complex":[90],"challenges":[91],"mapping":[93],"meeting":[97],"diverse,":[98],"stringent":[99],"standards":[101],"across":[102],"global":[103],"such":[105],"FDA":[107],"(US),":[108],"EMA":[109],"(Europe),":[110],"PMDA":[111],"(Japan),":[112],"HC":[113],"(Canada),":[114],"CDSCO":[115],"(India),":[116],"TGA":[117],"(Australia)":[118],"etc.":[119],"This":[120],"review":[121],"provides":[122],"comprehensive":[124],"analysis":[125],"of":[126,151],"the":[127,149],"evolving":[128],"trends,":[129],"scientific":[130],"strategies,":[131],"frameworks":[134],"shaping":[135],"highlighting":[139],"critical":[140],"stages":[141],"API,":[143],"excipient":[144],"selection":[145],"bioequivalence,":[147],"role":[150],"advanced":[152],"evaluation":[155],"ensuring":[158],"stability,":[160],"approval":[163],"readiness.":[164]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}